Harmonized Index of Consumer Prices: Pharmaceutical Products for European Economic Area (EEA18-2004, EEA28-2006, EEA30)

CP0611E3CCM086NEST • Economic Data from Federal Reserve Economic Data (FRED)

Latest Value

120.29

Year-over-Year Change

2.05%

Date Range

12/1/1999 - 7/1/2025

Summary

The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products tracks changes in the prices of medicinal products across the European Economic Area (EEA). This trend is a crucial indicator for monitoring healthcare costs and pharmaceutical affordability.

Analysis & Context

This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.

Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.

About This Dataset

The HICP for Pharmaceutical Products measures the price changes of a basket of over-the-counter and prescription medications purchased by consumers in the EEA. It is a harmonized, EU-wide index that allows for cross-country comparisons of consumer price inflation in the pharmaceutical sector.

Methodology

The data is collected by national statistical agencies and compiled by Eurostat using standardized methodology.

Historical Context

This index is widely used by policymakers, central banks, and market analysts to assess cost-of-living changes and inform pharmaceutical and healthcare policies.

Key Facts

  • The EEA comprises 30 countries, including the 27 EU member states and 3 EFTA states.
  • Pharmaceutical products account for around 2% of the total HICP basket.
  • The index is published monthly with a 1-2 month lag.

FAQs

Q: What does this economic trend measure?

A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products measures the changes in prices of medicinal products purchased by consumers in the European Economic Area (EEA).

Q: Why is this trend relevant for users or analysts?

A: This index is a crucial indicator for monitoring healthcare costs and pharmaceutical affordability, and it is widely used by policymakers, central banks, and market analysts to assess cost-of-living changes and inform pharmaceutical and healthcare policies.

Q: How is this data collected or calculated?

A: The data is collected by national statistical agencies and compiled by Eurostat using standardized methodology.

Q: How is this trend used in economic policy?

A: This index is used by policymakers, central banks, and market analysts to assess cost-of-living changes and inform pharmaceutical and healthcare policies.

Q: Are there update delays or limitations?

A: The index is published monthly with a 1-2 month lag.

Related Trends

Citation

U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for European Economic Area (EEA18-2004, EEA28-2006, EEA30) (CP0611E3CCM086NEST), retrieved from FRED.